OCTA in Epivascular Glia After Dex Implant

Federico II University

Status: Completed

Conditions: Diabetic Retinopathy

Treatments: Drug: Dexamethasone intravitreal implant

Study type: Observational

Funder types: Other

Identifiers

NCT05600179

0110/2022

Details and patient eligibility

About

The aim of this prospective study was for the first time, to analyze specific morphologic features in diabetic eyes with macular oedema, such as changes of the foveal avascular zone and the presence of epivascular glia, and see how they would change after dexamethasone intravitreal implant

Enrollment: 38 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• diabetic retinopathy complicated by macular edema

Exclusion criteria

• congenital eye disorders,
• previous diagnosis of other ocular diseases
• history of vitreous hemorrhage

Trial design

38 participants in 2 patient groups

patients with diabetic macular edema

Treatment:

Drug: Dexamethasone intravitreal implant

healthy patients